Skip to content

Harrow HROW R&D credit carryforward

R&D credit carryforward at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$6.99M-19.2%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch.

The official record: Harrow’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's r&d credit carryforward.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's r&d credit carryforward?
Harrow (HROW) reported r&d credit carryforward of $4.79M in Q4 2025.
What is the long-term trend for Harrow's r&d credit carryforward?
Over 2 years (2020 to 2025), Harrow's r&d credit carryforward has grown at a 183.5% compound annual growth rate (CAGR), from $596K to $4.79M.
What does r&d credit carryforward mean?
The value of research and development tax credits that the company has earned but has not yet been able to utilize to offset tax obligations. These carryforwards represent a future tax benefit that can improve cash flow once the company generates sufficient taxable income. This metric highlights the long-term value generated from the company's innovation and R&D investments.